Skip to main content
. 2019 Dec 3;245(3):201–212. doi: 10.1177/1535370219890873

Figure 1.

Figure 1.

GSH/GSSG ratio in plasma derived from healthy control subjects (CTR) and FRDA patients before (FRDA) and after two month (FRDA post-2 months) tocotrienol supplementation. Data are presented as Mean ± SD. ANOVA (P =0.0089) and two-tailed Student’s t-test were applied. Significance was maintained after P value false discovery rate (FDR) correction. Significance: (*) P < 0.05.